Type 2 Diabetes: Combining GLP-1 Therapy with Lifestyle Changes Reduces Heart Risk Individuals with type 2 diabetes (T2D) can significantly lower their risk of cardiovascular disease by combining the apply …
Tag:
Receptor
-
-
Technology
Dapiglutide Trial: Dual Gut Hormone Agonist Shows Promise But Fails to Beat Placebo for Obesity
Dapiglutide: Novel GLP-1/GLP-2 Agonist Shows Promise in Early Obesity Trials A new drug, dapiglutide, combining GLP-1 and GLP-2 receptor activation, is being investigated as a potential treatment for obesity. Early …
-
Switchable CAR-T Cells Offer New Hope for Cancer Treatment Engineered immune cells, known as chimeric antigen-receptor (CAR) T cells, have revolutionized the treatment of blood cancers, but limitations remain. Researchers …
-
GLP-1s and Tirzepatide: Weighing Benefits Against Emerging Risks Widely used medications like GLP-1 receptor agonists (GLP-1RAs) and tirzepatide have become popular for weight loss and diabetes management. While offering significant …
-
DMT Shows Promise in Rapidly Reducing Depressive Symptoms A recent clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for …
-
Chronic Inflammation and Cancer: A Deep Dive into Mechanisms, Therapies, and Future Directions Chronic inflammation is increasingly recognized not merely as a consequence of cancer, but as a key driver …
-
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’ ability to evade attack by the body’s immune system, a new study …
-
Widely used yet often underestimated, betel nut chewing poses significant health risks, and researchers continue to search for effective prevention and treatment strategies. Review: Understanding betel nut addiction: a review …
-
Novel Material Developed to Enhance Cancer Immunotherapy Table of Contents Novel Material Developed to Enhance Cancer Immunotherapy Understanding the Challenge in cancer Immunotherapy The EdUHK Innovation: A Novel Biomaterial Key …
-
Novel Therapeutic Strategy Targets Aggressive Triple-Negative Breast Cancer Through ATR and PKMYT1 Co-Inhibition Houston, TX – december 26, 2025 – A groundbreaking study published today in Science Translational Medicine details …